Literature DB >> 9752874

Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients.

H Leverstein1, J E van der Wal, R M Tiwari, H Tobi, I van der Waal, D M Mehta, G B Snow.   

Abstract

BACKGROUND: Optimal management of malignant epithelial parotid tumours requires knowledge of the available therapeutic modalities and the different biological characteristics. The aim of the study was to review the characteristics of patients at presentation, histological classification, disease-free and overall survival rates, and the results of the applied treatment policy regarding the facial nerve and neck.
METHODS: Between 1974 and 1995 a total of 65 patients was treated with curative intent for a previously untreated malignant epithelial parotid gland tumour. All patients underwent some type of parotidectomy, 20 of whom had an en bloc radical neck dissection. In selected cases the facial nerve or its branches were peeled off the tumour thus violating the objective of tumour-free margins and relying heavily on the efficacy of postoperative radiotherapy. In total 51 patients received postoperative radiotherapy. None of the patients was lost to follow-up.
RESULTS: There were 12 locoregional failures (18 per cent). In only one of these 12 patients was salvage therapy successful; the remaining 11 patients died from the tumour. All but one of the eight patients with distant metastasis only died from the tumour. The estimated 5- and 10-year disease-free rates were 68 and 59 per cent respectively. The corresponding survival rates were 75 per cent and 67 per cent. A significant relationship could be observed between tumour stage and survival. The presence of lymph node metastases proved to be the strongest single prognostic factor.
CONCLUSION: In selected cases a conservative approach towards the facial nerve is justified.

Entities:  

Mesh:

Year:  1998        PMID: 9752874     DOI: 10.1046/j.1365-2168.1998.00820.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors.

Authors:  Guevara-Canales Janet-Ofelia; Morales-Vadillo Rafael; Guzmán-Arias Guillermo; Cava-Vergiú Carlos-Enrique; Robello-Malatto José-Martín; Guerra-Miller Henry; Montes-Gil Jaime-Enrique
Journal:  J Maxillofac Oral Surg       Date:  2016-07-29

Review 3.  Cancer of the parotid gland: role of 7th nerve preservation.

Authors:  Jeffrey D Spiro; Ronald H Spiro
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

4.  [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].

Authors:  H Kokemüller; N Brüggemann; P Brachvogel; A Eckardt
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-07

5.  Neoplasms of the parotid gland in northern Poland, 1991-2000: an epidemiologic study.

Authors:  Tomasz Przewoźny; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-29       Impact factor: 2.503

6.  Are all prognostic factors in parotid gland carcinoma well recognized?

Authors:  Dominik Stodulski; Boguslaw Mikaszewski; Czeslaw Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

7.  Clinico-pathological and treatment-related factors influencing survival in parotid cancer.

Authors:  A G Renehan; E N Gleave; N J Slevin; M McGurk
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

8.  Metastatic Malignant Melanoma of Parotid Gland with a Regressed Primary Tumor.

Authors:  M Mustafa Kılıçkaya; Giray Aynali; Ali Murat Ceyhan; Metin Çiriş
Journal:  Case Rep Otolaryngol       Date:  2016-07-05

9.  Nuclear Multidrug Resistance-Related Protein 1 Is Highly Associated with Better Prognosis of Human Mucoepidermoid Carcinoma through the Suppression of Cell Proliferation, Migration and Invasion.

Authors:  Bo-Lei Cai; Yan Li; Liang-Liang Shen; Jin-Long Zhao; Yuan Liu; Jun-Zheng Wu; Yan-Pu Liu; Bo Yu
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.